Search

Your search keyword '"Duvivier, Claudine"' showing total 432 results

Search Constraints

Start Over You searched for: Author "Duvivier, Claudine" Remove constraint Author: "Duvivier, Claudine"
432 results on '"Duvivier, Claudine"'

Search Results

1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

2. Impact of vaccination with third generation modified vaccinia Ankara and sexual behaviour on mpox incidence in men who have sex with men: analysis among participants of the ANRS-174 DOXYVAC trial

3. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design

8. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design

10. A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial

11. Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium

12. Differences in integrated assessment and management of non‐communicable diseases (NCDs) for people with HIV across the WHO European region.

13. High proportion of post-migration HIV acquisition in migrant men who have sex with men receiving HIV care in the Paris region, and associations with social disadvantage and sexual behaviours: results of the ANRS-MIE GANYMEDE study, France, 2021 to 2022.

14. Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial

19. Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort

20. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

22. Weight gain following the single substitution of tenofovir disoproxil fumarate by tenofovir alafenamide in HIV‐infected people from the French Dat'AIDS cohort: A propensity score‐matched analysis.

24. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort

25. Impact on renal function of daily and on-demand HIV pre-exposure prophylaxis in the ANRS-PREVENIR study

27. Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

29. Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)

30. Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression

32. Smoking‐associated morbidities on computed tomography lung cancer screens in HIV‐infected smokers

33. Low-level viral loads and virological failure in the integrase strand transfer era.

34. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe

35. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV:results from the EuroSIDA study

36. High syphilis prevalence and incidence in people living with HIV and Preexposure Prophylaxis users: A retrospective review in the French Dat’AIDS cohort

37. No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy

38. A highly virulent variant of HIV-1 circulating in the Netherlands

39. Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France

40. Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study

41. Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study—IMEA 055.

42. A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial

43. Striking Differences in Weight Gain after Cart Initiation Depending on Early or Late Presentation: Results from the ANRS CO4 FHDH Cohort

44. Higher Mortality in People Living with HIV after Cure of Hepatitis C by Direct-Acting Antivirals Compared to Those Without Hepatitis C: Results from the ANRS CO4 FHDH Cohort

46. HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study)

47. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study

48. HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis

50. Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV

Catalog

Books, media, physical & digital resources